Solitomab

Known as: Anti-EpCAM BiTE 
A recombinant bispecific monoclonal antibody directed against both CD3 and epithelial cell adhesion molecule (EpCAM) with potential immunomodulating… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2015
012320082015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Uterine serous carcinoma is an aggressive form of endometrial cancer that carries an extremely poor prognosis… (More)
Is this relevant?
2015
2015
BACKGROUND Uterine and ovarian carcinosarcomas (CS) are rare but highly aggressive gynecologic tumors which carry an extremely… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2015
2015
BACKGROUND Solitomab is a novel, bispecific, single-chain antibody that targets epithelial cell adhesion molecule (EpCAM) on… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
Bispecific antibodies play an important role in immunotherapy. They have received intense interest from pharmaceutical… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 7
Is this relevant?
2008
2008
EpCAM (CD326) is one of the most frequently and highly expressed tumor-associated antigens known and recently has also been found… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?